The Center Party and Isamaa were coalition partners also in late 2018 when the reform deadline was postponed. Parties did not speak of the need to amend the reform in such concrete terms back then.
Head of the Estonian Chamber of Dispensing Pharmacists Karin Alamaa described the situation as politicians falling into the honey trap of pharmaceutical wholesalers.
“Saying that there will be an availability crisis is a convenient threat, but it’s just not true,” Alamaa said. She described the reform as successful, with over 200 pharmacies now owned by pharmacists.
Rumor has it some chains are preparing their pharmacies for the reform and pharmacists are in talks to acquire them. The latter have also said they are willing to open new pharmacies, provided a deal cannot be made with current owners.
“Therefore, we do not perceive an availability crisis at this time. It remains unclear what problem this decision seeks to solve and why. Approving the proposed changes would clearly constitute preferential treatment of three or four major pharmacy chains. The question is why,” Alamaa said.
The pharmacy market is all but split between three major enterprises today: Magnum Medical, Tamro and Apteekide Koostöö Hulgimüük, two of which are owned by brothers Margus and Aivar Linnamäe. Both are members of the coalition Isamaa party. Margus Linnamäe donated his party €50,000 last year, while his business partner Ivar Vendelin just donated €100,000 to the ruling Center Party.
The wholesalers’ main criticism of the reform is that the state has not procured a single effects analysis study. They believe a lot of pharmacies will simply close shop from April 1. Surveys ordered by wholesalers suggest Estonians are very happy with the country’s pharmacy network.